- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06668350
Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II (ASPIRE-II)
August 12, 2025 updated by: University of Oklahoma
Racial/Ethnic Differences in Appeal and Preference for Flavored Little Cigars/Cigarillos: A Multi-Method Approach to Inform Tobacco Policy
This multi-method project will recruit young adults who currently use cigarillos and examine the effects of different flavored cigarillo types (concept, characterizing, tobacco) on three measures of tobacco product appeal: subjective effects (e.g., taste, enjoyment, satisfaction, reward), actual smoking behavior (e.g., number of puffs), and tobacco product purchases via a simulated experimental tobacco marketplace.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
190
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Project Manager
- Phone Number: 1-405-271-7759
- Email: heal-lab@ouhsc.edu
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73012
- Recruiting
- TSET Health Promotion Research Center
-
Principal Investigator:
- Amy Cohn, PhD
-
Contact:
- Project Manager
- Phone Number: 405-271-1903
- Email: heal-lab@ouhsc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Ages18 to 34
- Smoke a little cigar or cigarillo (LCCs) "some days" or "everyday" (verified by brand name of the product);
- Ability to read English at an 8th grade level or higher; and
- No immediate plans to quit using tobacco
- > 1 prior experience, even 1 puff, with a flavored tobacco product
- U.S. Citizen or permanent resident of the United States.
Exclusion Criteria:
- Current use of nicotine replacement therapy (NRT) or stop smoking medication;
- Pregnant, planning to become pregnant, or currently breastfeeding;
- Past or current self-reported clinically significant heart disease or hypertension, or other smoking-related disease (by history) that preclude successful study completion;
- Inability to abstain from nicotine/tobacco products for at least 12 hours prior to lab sessions
- Report using the study cigarillo brand as their preferred brand (as this will likely unduly influence their perceptions)
- Unwillingness to use "untipped" (e.g., plastic or wood tip) little cigars/cigarillos.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Concept flavored cigarillo
Participants will smoke a concept flavored cigarillo in the lab
|
Participants will be assessed on several smoking outcomes including puffing behavior, subjective effects, and exhaled carbon monoxide
|
|
Experimental: Characterizing flavored cigarillo
Participants will smoke a characterizing flavored cigarillo
|
Participants will be assessed on several smoking outcomes including puffing behavior, subjective effects, and exhaled carbon monoxide
|
|
Experimental: Tobacco flavored cigarillo
Participants will smoke a tobacco flavored cigarillo
|
Participants will be assessed on several smoking outcomes including puffing behavior, subjective effects, and exhaled carbon monoxide
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Puff volume
Time Frame: From enrollment to the end of the study at 6 weeks
|
Volume of inhaled cigarillo puffs
|
From enrollment to the end of the study at 6 weeks
|
|
Exhaled carbon monoxide
Time Frame: From enrollment to the end of the study at 6 weeks
|
Changes in exhaled carbon monoxide (CO boot) following cigarillo smoking
|
From enrollment to the end of the study at 6 weeks
|
|
Subjective effects from smoking
Time Frame: From enrollment to the end of the study at 6 weeks
|
Self-reported reward from cigarillo smoking from a questionnaire.
This scale has 5 questions with response options ranging from 1 - not at all to 7 - extremely.
The score is averaged across the number of items.
Higher ratings indicate greater psychological reward.
|
From enrollment to the end of the study at 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 27, 2025
Primary Completion (Estimated)
February 1, 2029
Study Completion (Estimated)
June 30, 2029
Study Registration Dates
First Submitted
October 30, 2024
First Submitted That Met QC Criteria
October 30, 2024
First Posted (Actual)
October 31, 2024
Study Record Updates
Last Update Posted (Actual)
August 17, 2025
Last Update Submitted That Met QC Criteria
August 12, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- ACS CHERC
- CHERC-24-1160021-01-CHERC (Other Grant/Funding Number: American Cancer Society)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.